Home / Publications / Pain Research Forum / Papers of the Week / Efficacy and Safety of Apremilast in Patients With Limited Skin Involvement, Plaque Psoriasis in Special Areas, and Impaired Quality of Life: Results From the EMBRACE Randomized Trial.
Efficacy and Safety of Apremilast in Patients With Limited Skin Involvement, Plaque Psoriasis in Special Areas, and Impaired Quality of Life: Results From the EMBRACE Randomized Trial.
Manifestations of psoriasis in special areas are difficult to treat and are associated with a high disease burden and significant quality of life (QoL) impairment. Topical therapies may be inadequate for these patients, necessitating systemic treatment.
